RNAZ
Transcode Therapeutics IncNASDAQ
Healthcare • Biotechnology
Factor tilt: Micro-Cap Blend
$1.49-1.32%
Close Nov 6, 2026
- Market cap
- $25.23M
- 1 month
- -12.9%
- 3 months
- -61.6%
- 1 year
- -86.7%
- 52-week range
- $1.49$12.34
- Dividend
- No dividends on record
- Short interest
- 2.6% of float55K shares · settled Oct 15, 2026 · +5.6% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- -$42.78M
- Free cash flow
- —
- Book value
- $138.36M
- Total debt
- $652.41K
- P/E
- —
- Price / sales
- —
- Price / book
- 0.2×
- FCF yield
- —
- Net margin
- —
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Transcode Therapeutics Inc
TransCode Therapeutics, Inc., a clinical-stage company, develops immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers.
Read more
The company's therapeutic candidate comprises SEVIPROTIMUT-L for the adjuvant treatment of patients with Stages IIB and IIC melanoma that has completed Phase 2 clinical trial; TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others that has completed Phase 1 clinical trial. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; and TTX-siMYC, an siRNA-based MYC inhibitor. The company is also developing oncolytic virus therapy. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
- Website
- transcodetherapeutics.com
- Headquarters
- Boston, MA, United States
- Employees
- 12
- Listed
- Jul 8, 2021
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 3, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 14, 2026 | — | — | — | -$6.8M | -$6.7M |
| Mar 2026filed May 15, 2026 | — | — | — | -$7.3M | -$17.8M |
| Dec 2025 | — | — | — | -$6.5M | -$13.4M |
| Sep 2025filed Nov 14, 2025 | — | — | — | -$4.6M | -$4.9M |
| Jun 2025filed Aug 14, 2025 | — | — | — | -$4.2M | -$4.3M |
| Mar 2025filed May 14, 2025 | — | — | — | -$3.2M | -$12.1M |
| Dec 2024filed Jan 15, 2025 | — | — | — | -$2.1M | -$2.4M |
| Sep 2024filed Nov 14, 2024 | — | — | — | -$2.2M | -$2.3M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Apr 15, 2026 | — | — | — | -$28.0M | -$34.7M |
| Dec 2024filed Apr 30, 2025 | — | — | — | -$15.7M | -$16.8M |
| Dec 2023filed Apr 1, 2024 | — | — | — | -$19.4M | -$18.5M |
| Dec 2022filed Mar 31, 2023 | — | — | — | -$18.7M | -$17.6M |
| Dec 2021filed Mar 31, 2022 | — | — | — | -$6.2M | -$6.8M |
| Dec 2020filed Dec 31, 2020 | — | — | — | -$726.6K | -$2.3M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched RNAZ. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
54,968 shares short
+2,906 shares (+5.6%) vs Sep 30, 2026
2.6% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
52,062 shares short
-9,341 shares (-15.2%) vs Sep 15, 2026
Share of float unavailable. Published Oct 9, 2026.
Settlement Sep 15, 2026
61,403 shares short
+15,425 shares (+33.5%) vs Aug 31, 2026
9.5% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
45,978 shares short
+15,068 shares (+48.7%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
30,910 shares short
+2,658 shares (+9.4%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
28,252 shares short
-6,194 shares (-18%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind RNAZ’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 28 · reverse split
Effective May 15, 2025
Each 28 pre-split shares become 1 post-split share.
Source: EODHD
1 for 33 · reverse split
Effective Dec 4, 2024
Each 33 pre-split shares become 1 post-split share.
Source: EODHD
1 for 40 · reverse split
Effective Jan 16, 2024
Each 40 pre-split shares become 1 post-split share.
Source: EODHD
1 for 20 · reverse split
Effective May 23, 2023
Each 20 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if RNAZ is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
1 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Aug 14, 2026
Insider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
8 filers reported a long position in RNAZ for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 8 hold
100%
of the 33.5K shares 13-F filers reported
Moves vs Q1 2026
1 added1 trimmed
2 new · 4 unchanged
Net shares held
-27.4%
across the 6 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Yorkville Advisors Global, LP | $122K · 19.6K shares | 19.6K | New |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $40.6K · 6.5K shares | 6.5K | Unchanged |
| 3 | VANGUARD FIDUCIARY TRUST CO | $18.5K · 3K shares | 3K | Unchanged |
| 4 | UBS Group AG | $17.9K · 2.9K shares | 2.9K | -65.2% |
| 5 | FMR LLC | $4.4K · 706 shares | 706 | New |
| 6 | Tower Research Capital LLC (TRC) | $4.2K · 677 shares | 677 | +196.9% |
| 7 | WELLS FARGO & COMPANY/MN | $342 · 55 shares | 55 | Unchanged |
| 8 | SBI Securities Co., Ltd. | $75 · 12 shares | 12 | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of RNAZ file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 3, 2026 | CK Life Sciences Intl (Holdings) Inc13D · activist · amended | 83.9% |
| Jul 28, 2026 | CIK 173237413G · passive | 9.94% |
| Jul 28, 2026 | Braci Elena Rosa13G · passive | 6.17% |
| Jul 28, 2026 | Katzman Daniel Eduardo13G · passive | 5.16% |
| Apr 20, 2026 | YA II PN Ltd13G · passive | 9.9% |
Get the Full Analysis for RNAZ
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.